Diagnosis to Treatment Timeline
June 29 | Appointment with family nurse practitioner for chest wall pain |
July 5 | Bone X-rays series |
July 6 | Phone call from PCC reporting abnormalities in ribs and pelvis. Recommended CT scan. |
July 12 | CT scan |
July 13 | Appointment with PCC. Results of CT scan show rib fractures and metastatic breast cancer in ribs, pelvis, and cervico-thoracic spine. Phone call from general oncologist recommending bone scan and follow-up appointment. |
July 15 | Told brother and daughter |
Week of July 16 | Told key colleagues at work, 2 close friends and other 2 brothers |
July 18 | Bone scan |
July 25 | Appointment with general oncologist. Recommended seeing his colleague, an oncologist who specializes in breast cancer. |
July 2 | First appointment with physical therapist |
July 27 | Told mother |
July 31 | Bone biopsy |
Week of August 6 | Began to tell more extended family members |
August | Brain MRI for recurrent headaches |
August | First appointment with breast cancer oncologist. Recommends molecular profiling of cancer cells from bone biopsy and starting Zometa to prevent further “bone events.” |
August 17 | Dental evaluation before starting Zometa |
August 28 | First infusion of Zometa |
August 30 | Scheduled follow-up appointment with breast cancer oncologist, but canceled and rescheduled (after several phone calls) to next day because molecular profiling results not back |
August 31 | Follow-up appointment with breast cancer oncologist. Decision to start carboplatin after reviewing lots of treatment options. Also met with genetic counselor. |
Week of September 3 | Informed faculty and staff in my units. Informed college deans/directors. Also told colleagues in the community, eg, hospital board members. |
September 7 | Pre-op appointment with surgeon for port placement |
September 10 | Port placement |
September 11 | Chemotherapy education with pharmacist |
September 12 | First chemotherapy |
CT = computed tomography; PCC = primary care clinician; MRI = magnetic resonance imaging.